IL22 and Hepatic fibrosis: The evidence for IL-22-mediated anti-fibrotic effects in the liver is quite strong; e.g., IL-22 was shown to contain liver fibrosis and promote its resolution in a mouse model of CCL4-induced liver injury and to induce HSC senescence [100].